In the same South African study, a new three-marker serum biosignature (adipsin, Aβ42, and IL-10), which diagnosed childhood TBM with sensitivity of 82.6% and specificity of 75.0%, alongside several individual candidate biomarkers were identified (90). The gene discussed is IL10; the disease is meningeal tuberculosis.